Cipla to acquire Inzpera Healthsciences for ₹110.65 Crore EP News Bureau Nov 4, 2025 Cipla Limited has announced that it will acquire a 100% stake in Inzpera Healthsciences for about ₹110.65 crore. Once completed,…
US FDA approves Novartis’ eltrombopag Sanjiv Das Aug 25, 2015 The approval was based on two randomised, double-blinded, placebo-controlled trials enrolling paediatric patients with chronic ITP…
